SMTL ID : 1vbb.2 (4 other biounits)

POLIOVIRUS (TYPE 3, SABIN STRAIN) (P3/SABIN, P3/LEON/12A(1)B) COMPLEXED WITH R80633

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

hetero-5-5-5-5-mer

Ligands

5 x ILE- SER- GLU- VAL: POLIOVIRUS TYPE 3(Non-covalent)

ILE-SER-GLU-VAL.1: 4 residues within 4Å: Chain D: A.2, Q.3, V.4, S.5 4 PLIP interactions: 4 interactions with chain D Hydrophobic interactions: D:V.4 Hydrogen bonds: D:A.2, D:Q.3, D:V.4 ILE-SER-GLU-VAL.4: 4 residues within 4Å: Chain H: A.2, Q.3, V.4, S.5 4 PLIP interactions: 4 interactions with chain H Hydrophobic interactions: H:V.4 Hydrogen bonds: H:A.2, H:Q.3, H:V.4 ILE-SER-GLU-VAL.7: 4 residues within 4Å: Chain L: A.2, Q.3, V.4, S.5 4 PLIP interactions: 4 interactions with chain L Hydrophobic interactions: L:V.4 Hydrogen bonds: L:A.2, L:Q.3, L:V.4 ILE-SER-GLU-VAL.10: 4 residues within 4Å: Chain P: A.2, Q.3, V.4, S.5 4 PLIP interactions: 4 interactions with chain P Hydrophobic interactions: P:V.4 Hydrogen bonds: P:A.2, P:Q.3, P:V.4 ILE-SER-GLU-VAL.13: 4 residues within 4Å: Chain T: A.2, Q.3, V.4, S.5 4 PLIP interactions: 4 interactions with chain T Hydrophobic interactions: T:V.4 Hydrogen bonds: T:A.2, T:Q.3, T:V.4

5 x J80: (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE(Non-covalent)

J80.2: 18 residues within 4Å: Chain A: I.108, T.109, Y.110, F.132, I.155, Y.157, P.179, S.180, I.181, I.192, V.194, V.197, Y.203, D.235, F.236, L.239 Chain C: A.24, I.25 16 PLIP interactions: 15 interactions with chain A, 1 interactions with chain C Hydrophobic interactions: A:I.108, A:I.108, A:Y.110, A:Y.110, A:F.132, A:Y.157, A:Y.157, A:Y.157, A:P.179, A:I.181, A:V.197, A:F.236, A:F.236, A:F.236, C:A.24 pi-Stacking: A:Y.203 J80.5: 18 residues within 4Å: Chain E: I.108, T.109, Y.110, F.132, I.155, Y.157, P.179, S.180, I.181, I.192, V.194, V.197, Y.203, D.235, F.236, L.239 Chain G: A.24, I.25 16 PLIP interactions: 15 interactions with chain E, 1 interactions with chain G Hydrophobic interactions: E:I.108, E:I.108, E:Y.110, E:Y.110, E:F.132, E:Y.157, E:Y.157, E:Y.157, E:P.179, E:I.181, E:V.197, E:F.236, E:F.236, E:F.236, G:A.24 pi-Stacking: E:Y.203 J80.8: 18 residues within 4Å: Chain I: I.108, T.109, Y.110, F.132, I.155, Y.157, P.179, S.180, I.181, I.192, V.194, V.197, Y.203, D.235, F.236, L.239 Chain K: A.24, I.25 16 PLIP interactions: 15 interactions with chain I, 1 interactions with chain K Hydrophobic interactions: I:I.108, I:I.108, I:Y.110, I:Y.110, I:F.132, I:Y.157, I:Y.157, I:Y.157, I:P.179, I:I.181, I:V.197, I:F.236, I:F.236, I:F.236, K:A.24 pi-Stacking: I:Y.203 J80.11: 18 residues within 4Å: Chain M: I.108, T.109, Y.110, F.132, I.155, Y.157, P.179, S.180, I.181, I.192, V.194, V.197, Y.203, D.235, F.236, L.239 Chain O: A.24, I.25 16 PLIP interactions: 15 interactions with chain M, 1 interactions with chain O Hydrophobic interactions: M:I.108, M:I.108, M:Y.110, M:Y.110, M:F.132, M:Y.157, M:Y.157, M:Y.157, M:P.179, M:I.181, M:V.197, M:F.236, M:F.236, M:F.236, O:A.24 pi-Stacking: M:Y.203 J80.14: 18 residues within 4Å: Chain Q: I.108, T.109, Y.110, F.132, I.155, Y.157, P.179, S.180, I.181, I.192, V.194, V.197, Y.203, D.235, F.236, L.239 Chain S: A.24, I.25 16 PLIP interactions: 15 interactions with chain Q, 1 interactions with chain S Hydrophobic interactions: Q:I.108, Q:I.108, Q:Y.110, Q:Y.110, Q:F.132, Q:Y.157, Q:Y.157, Q:Y.157, Q:P.179, Q:I.181, Q:V.197, Q:F.236, Q:F.236, Q:F.236, S:A.24 pi-Stacking: Q:Y.203

5 x MYR: MYRISTIC ACID(Covalent)

MYR.3: 10 residues within 4Å: Chain D: G.1, A.2, Y.31 Chain H: V.4, T.27, I.29, Y.31 Chain O: L.2 Ligands: MYR.6, MYR.15 3 PLIP interactions: 1 interactions with chain D, 2 interactions with chain H Hydrogen bonds: D:A.2, H:T.27 Hydrophobic interactions: H:I.29 MYR.6: 10 residues within 4Å: Chain H: G.1, A.2, Y.31 Chain L: V.4, T.27, I.29, Y.31 Chain S: L.2 Ligands: MYR.3, MYR.9 2 PLIP interactions: 1 interactions with chain L, 1 interactions with chain H Hydrophobic interactions: L:I.29 Hydrogen bonds: H:A.2 MYR.9: 10 residues within 4Å: Chain C: L.2 Chain L: G.1, A.2, Y.31 Chain P: V.4, T.27, I.29, Y.31 Ligands: MYR.6, MYR.12 2 PLIP interactions: 1 interactions with chain L, 1 interactions with chain P Hydrogen bonds: L:A.2 Hydrophobic interactions: P:I.29 MYR.12: 10 residues within 4Å: Chain G: L.2 Chain P: G.1, A.2, Y.31 Chain T: V.4, T.27, I.29, Y.31 Ligands: MYR.9, MYR.15 3 PLIP interactions: 2 interactions with chain T, 1 interactions with chain P Hydrophobic interactions: T:I.29 Hydrogen bonds: T:T.27, P:A.2 MYR.15: 10 residues within 4Å: Chain D: V.4, T.27, I.29, Y.31 Chain K: L.2 Chain T: G.1, A.2, Y.31 Ligands: MYR.3, MYR.12 3 PLIP interactions: 2 interactions with chain D, 1 interactions with chain T Hydrophobic interactions: D:I.29 Hydrogen bonds: D:T.27, T:A.2

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Grant, R.A. et al., Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design. Curr.Biol. (1994)

Release Date

1996-07-11

Peptides

POLIOVIRUS TYPE 3: AEIMQ
POLIOVIRUS TYPE 3: BFJNR
POLIOVIRUS TYPE 3: CGKOS
POLIOVIRUS TYPE 3: DHLPT

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
1

E
1

I
1

M
1

Q
1

B
2

F
2

J
2

N
2

R
2

C
3

G
3

K
3

O
3

S
3

D
4

H
4

L
4

P
4

T
4

POLIOVIRUS TYPE 3

POLIOVIRUS TYPE 3

POLIOVIRUS TYPE 3

POLIOVIRUS TYPE 3

Related Entries With Identical Sequence